- Home
- ATNM vs TCBS Comparison
ATNM vs TCBS Comparison
Compare ATNM & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- TCBS
- Stock Information
- Founded
- ATNM 2000
- TCBS 1934
- Country
- ATNM United States
- TCBS United States
- Employees
- ATNM N/A
- TCBS N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- TCBS Banks
- Sector
- ATNM Health Care
- TCBS Finance
- Exchange
- ATNM Nasdaq
- TCBS Nasdaq
- Market Cap
- ATNM 56.5M
- TCBS 48.6M
- IPO Year
- ATNM N/A
- TCBS N/A
- Fundamental
- Price
- ATNM $1.17
- TCBS $16.04
- Analyst Decision
- ATNM Strong Buy
- TCBS
- Analyst Count
- ATNM 4
- TCBS 0
- Target Price
- ATNM $8.75
- TCBS N/A
- AVG Volume (30 Days)
- ATNM 167.7K
- TCBS 3.1K
- Earning Date
- ATNM 03-28-2025
- TCBS 03-04-2025
- Dividend Yield
- ATNM N/A
- TCBS 1.00%
- EPS Growth
- ATNM N/A
- TCBS N/A
- EPS
- ATNM N/A
- TCBS N/A
- Revenue
- ATNM $81,000.00
- TCBS $9,858,000.00
- Revenue This Year
- ATNM $138.42
- TCBS N/A
- Revenue Next Year
- ATNM $16,957.05
- TCBS N/A
- P/E Ratio
- ATNM N/A
- TCBS N/A
- Revenue Growth
- ATNM N/A
- TCBS N/A
- 52 Week Low
- ATNM $1.07
- TCBS $13.11
- 52 Week High
- ATNM $10.24
- TCBS $16.49
- Technical
- Relative Strength Index (RSI)
- ATNM 46.97
- TCBS 61.54
- Support Level
- ATNM $1.15
- TCBS $15.90
- Resistance Level
- ATNM $1.29
- TCBS $16.25
- Average True Range (ATR)
- ATNM 0.07
- TCBS 0.36
- MACD
- ATNM 0.01
- TCBS 0.02
- Stochastic Oscillator
- ATNM 46.51
- TCBS 61.86
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.